Literature DB >> 29412482

Establishment of magnetic resonance imaging 3D reconstruction technology of orbital soft tissue and its preliminary application in patients with thyroid-associated ophthalmopathy.

Jie Shen1, Wei Jiang1, Yaosheng Luo1, Qiuyue Cai1, Zhangfang Li1, Zhiyi Chen1, Shidi Hu1, Lei Tang2.   

Abstract

OBJECTIVE: Effective management of thyroid-associated ophthalmopathy (TAO) requires precise identification of the disease activity period as it is responsive to immunosuppressive treatment. Quantitative evaluations of orbital soft tissue are useful for analysing disease stages. We aimed to establish a method for orbital soft tissue volume calculation based on magnetic resonance imaging (MRI) data using 3D reconstruction technology. Furthermore, we validated the accuracy and precision of this method and investigated volume differences between patients with TAO and healthy individuals.
MATERIALS AND METHODS: Using Mimics software for 3D reconstruction based on orbital MRI data, we quantitatively measured orbital fat volume (FV) and extraocular muscle volume (MV) using a manual phantom, and in patients with TAO and healthy volunteers (n = 10 each). The phantom was made using a combination of butter and chicken muscle and 2 observers measured its volume. Volume calculations were compared to a previously established standard volume. One observer measured a typical TAO case 10 times to calculate intra-observer variability while 3 observers independently measured 10 patients with TAO each to calculate interobserver variability. Orbital soft tissue volumes between 10 patients with TAO and 10 healthy individuals were compared.
RESULTS: The precision of calculations for the phantom between the 2 observers varied from -4.60% to -2.78% for FV and between -4.13% to 0.71% for MV. Mean differences among repetitive calculations were lower than 4%, except during measurement of MV, which was 5.84%. The intraclass correlation coefficient varied from 0.976 to 0.996. FV was 15.53 ± 3.06 mL in patients with TAO and 11.32 ± 1.68 mL(P = .001)in healthy individuals, while MV was 3.19 ± 0.82 mL in patients with TAO and 2.45 ± 0.57 mL(P = .030)in healthy individuals.
CONCLUSIONS: This method of calculating orbital soft tissue volumes based on MRI data and 3D reconstruction is both reliable and accurate as it yielded significant differences in tissue volume between patients with TAO and healthy individuals.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  3D reconstruction; orbital soft tissue volume; thyroid associated ophthalmopathy

Mesh:

Year:  2018        PMID: 29412482     DOI: 10.1111/cen.13564

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  4 in total

1.  Orbital volume measurements from magnetic resonance images using the techniques of manual planimetry and stereology.

Authors:  Georgios Bontzos; Michael Mazonakis; Efrosini Papadaki; Thomas G Maris; Styliani Blazaki; Eleni E Drakonaki; Efstathios T Detorakis
Journal:  Natl J Maxillofac Surg       Date:  2020-06-18

2.  Preliminary study of abnormalities in saccade dynamics in patients with hyperthyroidism with no pre-existing eye damage.

Authors:  Yan Sun; Xinhui Xie; Yongxia Xu; Chen Wang; Xiaoming Kong
Journal:  Exp Ther Med       Date:  2020-01-17       Impact factor: 2.447

3.  Detection of active and inactive phases of thyroid-associated ophthalmopathy using deep convolutional neural network.

Authors:  Chenyi Lin; Xuefei Song; Huifang Zhou; Xianqun Fan; Lunhao Li; Yinwei Li; Mengda Jiang; Rou Sun
Journal:  BMC Ophthalmol       Date:  2021-01-14       Impact factor: 2.209

4.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.